{"id":"https://openalex.org/W2017407904","doi":"https://doi.org/10.1254/jphs.08297fp","title":"An Antihyperkinetic Action by the Serotonin 1A\u2013Receptor Agonist Osemozotan Co-administered With Psychostimulants or the Non-stimulant Atomoxetine in Mice","display_name":"An Antihyperkinetic Action by the Serotonin 1A\u2013Receptor Agonist Osemozotan Co-administered With Psychostimulants or the Non-stimulant Atomoxetine in Mice","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W2017407904","doi":"https://doi.org/10.1254/jphs.08297fp","mag":"2017407904","pmid":"https://pubmed.ncbi.nlm.nih.gov/19270432"},"language":"en","primary_location":{"id":"doi:10.1254/jphs.08297fp","doi":"https://doi.org/10.1254/jphs.08297fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.08297fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/109/3/109_08297FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jphs/109/3/109_08297FP/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005613601","display_name":"Rie Tsuchida","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rie Tsuchida","raw_affiliation_strings":["Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067787378","display_name":"Masahiro Kubo","orcid":"https://orcid.org/0000-0002-3229-7609","observed_orcids":["https://orcid.org/0000-0002-3229-7609"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Kubo","raw_affiliation_strings":["Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053102007","display_name":"Mariko Kuroda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mariko Kuroda","raw_affiliation_strings":["Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046088409","display_name":"Yasuhiro Shibasaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Shibasaki","raw_affiliation_strings":["Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058123444","display_name":"Norihito Shintani","orcid":"https://orcid.org/0000-0002-7850-9064","observed_orcids":["https://orcid.org/0000-0002-7850-9064"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Norihito Shintani","raw_affiliation_strings":["Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037377890","display_name":"Michikazu Abe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michikazu Abe","raw_affiliation_strings":["Pharmacology Department IV, Mitsubishi Tanabe Pharma Corporation, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacology Department IV, Mitsubishi Tanabe Pharma Corporation, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011105457","display_name":"Katalin K\u00f6ves","orcid":"https://orcid.org/0000-0002-3244-5202","observed_orcids":["https://orcid.org/0000-0002-3244-5202"]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"Katalin K\u00f6ves","raw_affiliation_strings":["Department of Human Morphology and Developmental Biology, Faculty of Medicine, Semmelweis University, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Human Morphology and Developmental Biology, Faculty of Medicine, Semmelweis University, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027301316","display_name":"Hitoshi Hashimoto","orcid":"https://orcid.org/0000-0001-6548-4016","observed_orcids":["https://orcid.org/0000-0001-6548-4016"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Hashimoto","raw_affiliation_strings":["Center for Child Mental Development, Graduate School of Medicine, Osaka University, Japan","Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Child Mental Development, Graduate School of Medicine, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]},{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"last","author":{"id":null,"display_name":"Akemichi Baba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akemichi Baba","raw_affiliation_strings":["Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Japan","institution_ids":["https://openalex.org/I98285908"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":null,"fwci":0.4689,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.56034383,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"109","issue":"3","first_page":"396","last_page":"402"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6528000235557556,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.6528000235557556,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.3330000042915344,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0052999998442828655,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-ht1a-receptor","display_name":"5-HT1A receptor","score":0.8700000047683716},{"id":"https://openalex.org/keywords/hyperactivity","display_name":"hyperactivity","score":0.765999972820282},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.9610000252723694},{"id":"https://openalex.org/keywords/amphetamine","display_name":"amphetamine","score":0.7870000004768372},{"id":"https://openalex.org/keywords/methamphetamine","display_name":"methamphetamine","score":0.9070000052452087},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9670000076293945},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/way-100635","display_name":"WAY-100635","score":0.9100000262260437},{"id":"https://openalex.org/keywords/serotonergic-neurotransmission","display_name":"serotonergic neurotransmission","score":0.8190000057220459},{"id":"https://openalex.org/keywords/hyperkinetic-disorder","display_name":"hyperkinetic disorder","score":0.8980000019073486},{"id":"https://openalex.org/keywords/locomotor-activity","display_name":"locomotor activity","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.8049198985099792},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7352638840675354},{"id":"https://openalex.org/C2777193897","wikidata":"https://www.wikidata.org/wiki/Q179452","display_name":"Amphetamine","level":3,"score":0.6941078901290894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6640357971191406},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.6415168642997742},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.6365064382553101},{"id":"https://openalex.org/C2780376393","wikidata":"https://www.wikidata.org/wiki/Q191924","display_name":"Methamphetamine","level":2,"score":0.5909422039985657},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.5495957732200623},{"id":"https://openalex.org/C2777450907","wikidata":"https://www.wikidata.org/wiki/Q3937260","display_name":"Ritanserin","level":5,"score":0.5185937881469727},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.49403196573257446},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48574715852737427},{"id":"https://openalex.org/C2776145449","wikidata":"https://www.wikidata.org/wiki/Q1706418","display_name":"Dextroamphetamine","level":4,"score":0.4170989692211151},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2957232594490051},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.27482473850250244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2619211971759796},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.24509841203689575},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.16577711701393127},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.14501067996025085},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.09083530306816101}],"mesh":[{"descriptor_ui":"D000069445","descriptor_name":"Atomoxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000661","descriptor_name":"Amphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000697","descriptor_name":"Central Nervous System Stimulants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004146","descriptor_name":"Dioxanes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004146","descriptor_name":"Dioxanes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004149","descriptor_name":"Dioxoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006948","descriptor_name":"Hyperkinesis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008813","descriptor_name":"Mice, Inbred ICR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011437","descriptor_name":"Propylamines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018759","descriptor_name":"Adrenergic Uptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D044282","descriptor_name":"Receptor, Serotonin, 5-HT1A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058825","descriptor_name":"Serotonin 5-HT1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058829","descriptor_name":"Serotonin 5-HT1 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1254/jphs.08297fp","doi":"https://doi.org/10.1254/jphs.08297fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.08297fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/109/3/109_08297FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:19270432","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19270432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:fc7e4a9bf616418d8f0af5dfac3fd551","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/fc7e4a9bf616418d8f0af5dfac3fd551","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 109, Iss 3, Pp 396-402 (2009)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1254/jphs.08297fp","doi":"https://doi.org/10.1254/jphs.08297fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.08297fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/109/3/109_08297FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322142","display_name":"Minist\u00e8re des Affaires Etrang\u00e8res","ror":"https://ror.org/00dfd1509"},{"id":"https://openalex.org/F4320325387","display_name":"Senri Life Science Foundation","ror":"https://ror.org/046m7f751"},{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2017407904.pdf","grobid_xml":"https://content.openalex.org/works/W2017407904.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W1788048136","https://openalex.org/W1982579212","https://openalex.org/W2005644211","https://openalex.org/W2008362610","https://openalex.org/W2008412558","https://openalex.org/W2011431839","https://openalex.org/W2031932912","https://openalex.org/W2031965284","https://openalex.org/W2038235621","https://openalex.org/W2042123414","https://openalex.org/W2057760214","https://openalex.org/W2066051567","https://openalex.org/W2066165173","https://openalex.org/W2095857831","https://openalex.org/W2098149780","https://openalex.org/W2102974182","https://openalex.org/W2123980944","https://openalex.org/W2130816992","https://openalex.org/W2151610969","https://openalex.org/W2151875422","https://openalex.org/W2258250981","https://openalex.org/W2289924778"],"related_works":["https://openalex.org/W2010229579","https://openalex.org/W2005704843","https://openalex.org/W2038235621","https://openalex.org/W2015419289","https://openalex.org/W2098149780","https://openalex.org/W2031932912","https://openalex.org/W2042123414","https://openalex.org/W1976902496","https://openalex.org/W2008362610","https://openalex.org/W1970777708"],"abstract_inverted_index":{"It":[0],"has":[1],"been":[2],"demonstrated":[3],"that":[4,24,44],"treatment":[5],"of":[6,64,67,89,124,135,157,173,187],"hyperactive":[7],"mice":[8,27,48,81],"with":[9,83,91,126],"psychostimulants":[10,69,140,189],"produced":[11,128],"a":[12,39,62,129,149,158],"calming":[13,130],"effect":[14,134,172],"depending":[15],"on":[16],"serotonergic":[17],"neurotransmission.":[18],"Our":[19],"previous":[20],"study":[21],"also":[22,101],"showed":[23],"hyperactivity":[25],"in":[26,38,80],"lacking":[28],"pituitary":[29],"adenylate":[30],"cyclase-activating":[31],"polypeptide":[32],"(PACAP)":[33],"was":[34,96,141],"ameliorated":[35],"by":[36,76,143],"amphetamine":[37,45,95],"serotonin":[40],"(5-HT)(1A)-dependent":[41],"manner":[42],"and":[43,190],"calmed":[46],"wild-type":[47],"given":[49],"the":[50,65,73,84,139,144,155,171,184,188],"5-HT(1A)":[51,85,145],"agonist":[52,86],"8-OH-DPAT.":[53],"Here,":[54],"we":[55],"examined":[56],"if":[57],"5-HT(1A)-mediated":[58,160],"pathways":[59],"can":[60],"be":[61],"determinant":[63],"action":[66],"other":[68],"as":[70,72],"well":[71],"non-stimulant":[74,116],"atomoxetine":[75,117,125,174,191],"examining":[77],"locomotor":[78],"activity":[79],"co-administered":[82],"osemozotan.":[87,176],"Co-administration":[88],"osemozotan":[90,110,127,136],"either":[92],"methamphetamine":[93],"or":[94],"not":[97,119,169],"only":[98],"antihyperkinetic,":[99],"but":[100,122],"decreased":[102],"locomotion":[103],"to":[104,138,165],"below":[105],"basal":[106],"levels.":[107],"In":[108],"contrast,":[109],"just":[111],"nullified":[112],"methylphenidate-induced":[113],"hyperactivity.":[114],"The":[115,132,177],"did":[118,168],"induce":[120],"hyperactivity,":[121],"co-administration":[123],"effect.":[131],"adjunctive":[133],"added":[137],"blocked":[142],"antagonist":[146],"WAY-100635":[147,163],"at":[148],"low":[150],"dose":[151],"(0.1":[152],"mg/kg),":[153],"suggesting":[154],"involvement":[156],"presynaptic":[159],"mechanism.":[161],"However,":[162],"(up":[164],"1":[166],"mg/kg)":[167],"block":[170],"plus":[175],"present":[178],"results":[179],"may":[180],"provide":[181],"insights":[182],"into":[183],"therapeutic":[185],"mechanisms":[186],"for":[192],"hyperkinetic":[193],"disorders.":[194]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}